Avingtrans Plc
("Avingtrans" or the "Company" or the "Group")
Director Dealings: Exercise of share options
Avingtrans (AIM:AVG), a manufacturer of critical components and associated services to the global aerospace, energy and medical sectors announces that it was notified on 29 October 2014 of the transactions described below in the ordinary shares of the Company by the directors.
On 29 October 2014, the Company was notified of the vesting and exercise of certain option awards over ordinary shares of 5p each in the Company ("Ordinary Shares") in the Executive Shared Ownership Plan ("the ExSOP "). The option awards were issued to the directors in September 2011 and the vesting criteria, being growth in adjusted basic earnings per share equalling the increase in the retail price index over the three year vesting period, has been achieved.
Details of the exercise of options by Steve McQuillan and Stephen King and the subsequent beneficial holdings of each director following the transactions are set out below:
Director |
Number of Options |
Number of Ordinary Shares which have vested to each Director
|
Beneficial interest in Ordinary Shares after the transaction |
Percentage interest in Ordinary Shares after the transaction |
Steve McQuillan |
195,000 |
117,028 |
330,566 |
1.2% |
|
|
|
|
|
Stephen King |
130,000 |
78,019 |
286,071 |
1.0% |
For further information, please contact:
Enquiries:
Avingtrans plc 0115 949 9020
Steve McQuillan, CEO
Stephen King, CFO
Numis
David Poutney (Corporate Broking) 0207 260 1000
Richard Thomas (Corporate Finance and Nominated Adviser)
Newgate Threadneedle 020 7653 9850
(Financial PR)
Josh Royston / Heather Armstrong
|
About Avingtrans
|